In studies conducted using ovalbumin-induced asthma models, tectorigenin reduced eosinophil infiltration and serum IL5 levels, indicating its ability to control inflammation and eosinophilia-related issues in asthma [182]. This evidence concerns the gene IL5 and asthma.